Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the...

40
Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University

Transcript of Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the...

Page 1: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young

RDB Jaquiss Duke University

Page 2: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Disclosures

• None

Page 3: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Current Paradigm for Palliation

• Stage I – shunt/band PROTECT PVR• Stage II – superior CPC RELIEVE VOLUME LOAD• Stage III – Fontan completion RELIEVE CYANOSIS

• If (when?) palliation fails - transplant

Page 4: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Normal

Page 5: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Single Ventricle

Page 6: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Fontan Circulation

Page 7: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Fontan Circulation

Page 8: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Conditional Freedom from Death or Transplant

5 years 94%

10 years 90%

15 years 87%

20 years 83%

How Well and How Long Does It Work?

Page 9: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

2

Conditional Survival

Atriopulmonary 25 years 76%

Lateral Tunnel 20 years 90%

Extracardiac 13 years 97%

A Very Large and Excellent Experience

Page 10: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

A Closer Look Survival Isn’t Everything

Page 11: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Problems with Fontan Circulation

• Low Cardiac Output (70% of Normal at Rest)– Impaired Exercise Capacity– pre-load (PVR) determined

• Thromboembolism• Arrythmias• Hepatopathy• Nephropathy

• Death

Page 12: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Developments in Fontan Surgery

• Description by Fontan and Baudet• Ten Commandments• Lateral Tunnel• Extracardiac• Staging• Fenestration• Fontan conversion• Intra/Extra• “Y” Grafts

Page 13: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Marc Gewillig Heart 2005;91:839-846

Page 14: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

“…pattern of endothelial dysfunction-induced remodeling due to chronic, non-pulsatile flow with in situ thrombotic lesions.”

Page 15: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Fontan Circulation

Page 16: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Modes of Fontan Failure

• Pump failure (LV<RV)– Intrinsic, iatrogenic, arrythmic, valvular

• Concept failure– “high”PVR leading to high Fontan pressure

• PLE, plastic bronchitis• Cyanosis (V-V collaterals)

Page 17: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Scope of Problem

• STS Congenital Database 7/2010 to 6/2014– 3245 “Fontan” operation (excluding conversions)

• 810/year entering pipeline

• Scientific Registry of Transplant Recipients

Page 18: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Total Heart Transplants – U.S.

Page 19: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.
Page 20: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Status 2 – 10% waitlist mortalityStatus 1 (inotropes) – 40% waitlist mortalityStatus 1 (ventilator) – 70% waitlist mortality

Page 21: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Changing Profile of Adult Heart Transplant 2002 and 2012

2002 2012

N % N %

UrgencyStatus

1A 660 34.8 1190 58.5

1B 723 38.2 743 36.5

2 509 26.9 102 5.0

Bridge No VAD 1454 76.8 1194 58.7

VAD 440 23.2 841 41.3

Page 22: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.
Page 23: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.
Page 24: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Application of LVAD

• Pump failure (LV<RV)– Intrinsic, iatrogenic, arrythmic, valvular

• Concept failure– “high”PVR leading to high Fontan pressure

• PLE, plastic bronchitis• Cyanosis (V-V collaterals)

Page 25: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

“As many as two thirds of adult Fontan patients who die or require transplantation do so with preserved ventricular function.”

Page 26: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

LVAD for Concept Failure – “Pulling”

Page 27: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Concept Failure – “Pushing”

“Fontan patients are doomed to a circulatory failure and

many of them will require a circulatory assistance as a bridge to transplantation.”

Page 28: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

RVAD vs. LVADPushing vs. Pulling

LVAD RVAD

Power Requirements X 0.25 X

Size Small Smaller

Embolic Consequences Very Bad Bad

Duarbility Unknown Unknown+++

Page 29: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.
Page 30: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.
Page 31: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Fig. 2 Aortic flow and superior vena cava (SVC) pressure at various phases of the experiment (mean flow and pressure of all 4 animals). Aortic flow decreased with institution of the Fontan circulation and was restored upon activation of the VAD. SVC pressu...

Page 32: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.
Page 33: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.
Page 34: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Factors Which Will Impact Future

Page 35: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.
Page 36: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

• Right Heart Failure after LVAD• ~10-15% temporary RVAD• ~20-30% moderate RVF

• Worse survival DT• Worse outcome BTT• Worse QOL

Page 37: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.
Page 38: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

“It's tough to make predictions, especially about the future.”

Yogi Berra

Page 39: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Transplant vs. Fontan-RVADTransplant Fontan + RVAD

Resting Cardiac Output Normal Normal

Exercise Cardiac Output Normal Normal

Hepatic Venous Pressure Normal to Slightly Elevated Normal

Chronic Anticoagulation No Yes

Power Cord No Probably

Immunosuppression Risks Yes No

Diabetes, Hypertension, Renal Failure

Yes No

Additional Surgery Needed Yes (Redo Tx) Yes (Redo VAD or Tx)

Page 40: Is “Four Stage Management” the Future of Univentricular Hearts? – Destination Therapy in the Young RDB Jaquiss Duke University.

Future Paradigm for Palliation

• Stage I – shunt/band PROTECT PVR• Stage II – superior CPC RELIEVE VOLUME LOAD• Stage III – Fontan completion RELIEVE CYANOSIS

– SET UP STAGE IV

• Stage IV– A. Pump Failure leads to transplant– B. Concept Failure leads to RVAD (timing?)